DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter ended September 30, 2015.
In the third quarter net revenue grew 1.8% year on year to $394.7 million from $387.6 million in the same quarter last year. This represented 7.5% constant currency growth and 4.1% constant dollar organic growth year on year.
Income from operations increased by 20.1% to $71.4 million or 18.1% of revenue compared to $59.4 million or 15.3% for the same quarter last year.
Net income increased by 22% to $61.5 million or $1.02 per share on a diluted basis, compared with $50.3 million or $0.79 per share for the same quarter last year.
Help employers find you! Check out all the jobs and post your resume.
In the third quarter net revenue grew 1.8% year on year to $394.7 million from $387.6 million in the same quarter last year. This represented 7.5% constant currency growth and 4.1% constant dollar organic growth year on year.
Income from operations increased by 20.1% to $71.4 million or 18.1% of revenue compared to $59.4 million or 15.3% for the same quarter last year.
Net income increased by 22% to $61.5 million or $1.02 per share on a diluted basis, compared with $50.3 million or $0.79 per share for the same quarter last year.
Help employers find you! Check out all the jobs and post your resume.
